Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.

Charlie Health reports that eating disorders are significantly influenced by genetics, with family history increasing risk ...

Tempus AI Inc. (NASDAQ:TEM) is one of the best AI stocks to buy according to hedge funds. On June 25, Ambry Genetics, which ...

Genomics is not just about science—it’s about your life. From how you respond to medications to your risk of chronic illness, ...

Results from the Phase III VEGA-3 trial show that a significantly higher number of patients with presbyopia who received ...

After several years of development, Processa Pharmaceuticals has determined that the nearest milestone for anticancer asset ...

A deeper understanding of how DNA changes over generations helps scientists learn why people differ and how diseases develop.

The first thing you learn about the Manning genealogy is that those boys are some fighting SOBs, all the way back to the ...

Genetic disease is believed to be linked to 41 percent of U.S. infants' deaths, while more than 2 million children have a ...

For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues.

Funding cuts and sky-high inflation have made researchers in Argentina thrifty and creative. What can U.S. colleagues learn ...

Fulgent Genetics is evolving into a precision medicine player with strong cash reserves, despite expected near-term losses.